ArticleTherapeutic advances in gastroenterology2025

Study design of the phase IV, randomized, placebo-controlled REMOdeling with Dupilumab in Eosinophilic esophagitis Long-term (REMODEL) trial.

Evan S Dellon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.